|  |  |  | Fold change | |
---|---|---|---|---|---|
Gene symbol | ProbeName | GenBank | Description | Overexpression | Knockdown |
Regulation of kinase activity | |||||
   RB1 | A_23_P204850 | NM_000321 | Retinoblastoma 1 (including osteosarcoma) | 0.74 | 1.53 |
   GADD45B | A_23_P142506 | NM_015675 | Growth arrest and DNA-damage-inducible, beta | 1.45 | 0.68 |
   PKIA | A_23_P31765 | NM_006823 | Protein kinase (cAMP-dependent, catalytic) inhibitor alpha | 0.68 | 1.41 |
   TIZ/ZNF675 | A_24_P931755 | D70835 | TRAF6-inhibitory zinc finger protein | 0.71 | 1.38 |
   SPRY4 | A_24_P269062 | NM_030964 | Sprouty homolog 4 (Drosophila) | 2.12 | 0.57 |
   DUSP6 | A_23_P139704 | NM_001946 | Dual specificity phosphatase 6 | 1.56 | 0.74 |
   RGS4 | A_23_P200737 | BC000737 | Regulator of G-protein signalling 4 | 1.83 | 0.65 |
   SPRED2 | A_32_P225854 | NM_181784 | Sprouty-related, EVH1 domain containing 2 | 1.52 | 0.72 |
   NRG1 | A_23_P315815 | NM_004495 | Neuregulin 1 | 1.51 | 0.74 |
   ZAK/MLTK_HUMAN | A_23_P318300 | NM_133646 | Sterile alpha motif and leucine zipper containing kinase AZK | 0.69 | 1.56 |
   EDN1 | A_23_P214821 | NM_001955 | Endothelin 1 | 2.33 | 0.49 |
   PRKD3 | A_24_P165656 | NM_005813 | Protein kinase D3 | 0.74 | 1.56 |
   KITLG | A_24_P133253 | NM_000899 | KIT ligand | 0.68 | 1.51 |
   C1QTNF6 | A_24_P211565 | NM_031910 | C1q and tumor necrosis factor related protein 6 | 0.47 | 1.54 |
   C5 | A_23_P71855 | NM_001735 | Complement component 5 | 0.42 | 2.62 |
   MAP4K5 | A_23_P205646 | BC036013 | Mitogen-activated protein kinase kinase kinase kinase 5 | 0.74 | 1.39 |
   CCNA1 | A_23_P48414 | NM_003914 | Cyclin A1 | 2.51 | 0.54 |
   CDKN2B | A_24_P360674 | NM_078487 | Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 1.81 | 0.71 |
   CKS1B | A_32_P175864 | BG205572 | CDC28 protein kinase regulatory subunit 1B | 1.45 | 0.64 |
   SERTAD1 | A_23_P218463 | NM_013376 | SERTA domain containing 1 | 1.51 | 0.75 |
Angiogenesis | |||||
   CEACAM1 | A_24_P382319 | NM_001712 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 0.60 | 1.78 |
   COL18A1 | A_23_P211212 | NM_030582 | Collagen, type XVIII, alpha 1 | 0.74 | 0.66 |
   CTGF | A_23_P19663 | NM_001901 | Connective tissue growth factor | 3.88 | 0.24 |
   MYH9 | A_23_P57497 | BC011915 | Myosin, heavy polypeptide 9, non-muscle | 1.34 | 0.75 |
   NRP2 | A_24_P50801 | AF280546 | Neuropilin 2 | 1.77 | 0.59 |
   PLXDC1 | A_23_P3911 | BC036059 | Plexin domain containing 1 | 0.63 | 1.38 |
   VEGF | A_23_P70398 | NM_003376 | Vascular endothelial growth factor | 0.75 | 1.31 |
   CXCL12 | A_23_P202448 | U19495 | Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) | 0.73 | 1.37 |
   CYR61 | A_23_P46426 | Z97068 | Cysteine-rich, angiogenic inducer, 61 | 1.74 | 0.44 |
   EDN1 | A_23_P214821 | NM_001955 | Endothelin 1 | 2.33 | 0.49 |
   SEMA5A | A_23_P213415 | NM_003966 | Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and sh | 0.28 | 2.26 |
   IL17F | A_23_P167882 | NM_052872 | Interleukin 17F | 1.78 | 2.01 |
   RUNX1 | A_24_P34155 | X90980 | Runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | 1.48 | 0.74 |
   THBS1 | A_23_P206212 | X04665 | Thrombospondin 1 | 1.97 | 0.59 |
Brain development | |||||
   APAF1 | A_23_P36611 | NM_181861 | Apoptotic protease activating factor | 0.58 | 1.36 |
   ATM | A_23_P35916 | NM_000051 | Ataxia telangiectasia mutated (includes complementation groups A, C and D) | 0.63 | 1.35 |
   CXCL12 | A_23_P202448 | U19495 | Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) | 0.73 | 1.37 |
   SEPP1 | A_23_P121926 | NM_005410 | Selenoprotein P, plasma, 1 | 0.66 | 1.36 |
   SMARCA1 | A_23_P44244 | NM_003069 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 | 0.43 | 1.40 |
   ATRX | A_24_P348660 | NM_000489 | Alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae) | 0.60 | 1.49 |
   NOTCH3 | A_32_P42895 | A_32_P42895 | Notch homolog 3 (Drosophila) | 0.68 | 1.46 |
   PRKG1 | A_23_P136041 | NM_006258 | Protein kinase, cGMP-dependent, type I | 0.43 | 1.34 |
   ATP7A | A_23_P217737 | NM_000052 | ATPase, Cu++ transporting, alpha polypeptide (Menkes syndrome) | 0.48 | 1.52 |
   FOXP2 | A_24_P16559 | AF467257 | forkhead box P2 | 0.67 | 1.40 |
   CEP290 | A_23_P36865 | AB002371 | Centrosome protein cep290 | 0.70 | 1.43 |
Response to DNA damage stimulus | |||||
   ZAK/NP_598407.1 | A_23_P318300 | NM_133646 | Sterile alpha motif and leucine zipper containing kinase AZK | 0.69 | 1.56 |
   BRCA1 | A_23_P207400 | NM_007294 | Breast cancer 1, early onset | 0.71 | 1.3 |
   ATM | A_23_P35916 | NM_000051 | Ataxia telangiectasia mutated (includes complementation groups A, C and D) | 0.63 | 1.35 |
   ATRX | A_24_P348660 | NM_000489 | Alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae) | 0.60 | 1.49 |
   BRCA2 | A_23_P99452 | NM_000059 | Breast cancer 2, early onset | 0.62 | 1.3 |
   BTG2 | A_23_P62901 | NM_006763 | BTG family, member 2 | 0.72 | 1.35 |
   Q6P2G2_HUMAN | A_24_P361457 | NM_173627 | Hypothetical protein FLJ35220 (FLJ35220) | 0.63 | 1.49 |
   RBM14 | A_23_P161644 | NM_032886 | RNA-binding motif protein 14 | 0.62 | 1.47 |
   MLH3 | A_24_P61520 | NM_014381 | MutL homolog 3 (E. coli) | 0.59 | 1.45 |
   N4BP2_HUMAN | A_24_P222114 | AK001542 | Nedd4 binding protein 2 | 0.52 | 1.47 |
   PMS1 | A_23_P40059 | NM_000534 | PMS1 postmeiotic segregation increased 1 (S. cerevisiae) | 0.65 | 1.34 |